in

Balchem increases Choline production by 50% due to rising demand in cognitive category

The completion of the 2,230 sqm facility expansion was announced by the company, with Frédéric Boned, Senior VP & General Manager, Human Nutrition & Health at Balchem, expressing enthusiasm: “We’re excited about the successful expansion of our VitaCholine manufacturing capacity. This milestone showcases our dedication to providing a larger supply of high-quality human choline to support our partners’ global growth in early childhood nutrition, dietary supplements, and food & beverage applications.”

Choline

Interest in choline and its cognitive health benefits has been on the rise in recent years, especially in the realm of maternal and infant health: In mid-2017, the American Medical Association urged higher choline levels in prenatal vitamins.

These calls are crucial given data from the National Health and Nutrition Examination Survey (NHANES) indicating that 90% of children, adults, and pregnant women are not meeting their choline requirements. The Adequate Intake (AI) for adults is 425 mg/day for women and 550 mg/day for men.

For pregnant women, the situation is particularly concerning due to choline’s role in infant neurodevelopment. (Recommendations increase to 450 mg for pregnant women and 550 mg for breastfeeding women.)

While much research has focused on the benefits for infants, such as a 2018 study showing how increased choline intake during pregnancy enhances newborn cognitive capacity, there is growing interest in choline’s impact on cognitive function across all ages.

What do you think?

Written by The Muscle Mag

Enhancing Combat-Sport Training Recovery with L-Glutamine

Achieving Success in Sports Nutrition Through Simplicity